Takeda Pharmaceutical CoTSE:4502 -0.98%64 Dividend Yield % is 3.92% as of Jun. 25, 2026, which is 11% below its 10-year median of 4.39. GuruFocus rates TSE:4502 with a GF Score™ of 64/100 and a GF Value™ of 円4,528.56 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 516 Drug Manufacturers companies, Takeda Pharmaceutical Co ranks better than 79.65% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Takeda Pharmaceutical Co is 3.92%.
The historical rank and industry rank for Takeda Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
TSE:4502'
s Dividend Yield % Range Over the Past 10 Years
Min: 2.71 Med: 4.39 Max: 6.17
Current: 3.92
During the past 13 years, the highest Dividend Yield of Takeda Pharmaceutical Co was 6.17%. The lowest was 2.71%. And the median was 4.39%.
TSE:4502's Dividend Yield % is ranked better than 79.65% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.005
vs TSE:4502: 3.92
During the past 12 months, Takeda Pharmaceutical Co's average Dividends Per Share Growth Rate was 2.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 3.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 2.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 0.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Takeda Pharmaceutical Co was 26.60% per year. The lowest was 0.00% per year. And the median was 0.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Takeda Pharmaceutical Co (TSE:4502) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4502 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's Dividend Yield % falls into.
Takeda Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Takeda Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 100.000000
2026-03-30
2026-03-31
2026-06-25
Cash Dividend
semi-annually
JPY:JPY 1.000000
JPY 100.000000
2025-09-29
2025-09-30
2025-12-01
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (TSE:4502) has a Dividend Yield % of 3.92% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Takeda Pharmaceutical Co and its competitors. This is 11% below median its historical median of 4.39. Over the past decade, Takeda Pharmaceutical Co's Dividend Yield % has ranged from 2.71 to 6.17. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #105 out of 516 companies in the Drug Manufacturers industry, placing it in the top 20.3%.
Is Takeda Pharmaceutical Co's Dividend Yield % too high?
Takeda Pharmaceutical Co's current Dividend Yield % of 3.92% is 11% below median its 10-year median of 4.39. Over the past 10 years, this metric has ranged from a low of 2.71 to a high of 6.17. The Drug Manufacturers industry median Dividend Yield % is 2.01. Takeda Pharmaceutical Co's value of 3.92% is 95.5% above this industry median. Based on the distribution chart, Takeda Pharmaceutical Co ranks #105 out of 516 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #105 out of 516 companies for Dividend Yield %. This places Takeda Pharmaceutical Co in the top 20% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.01. Takeda Pharmaceutical Co's value of 3.92% is 95.5% above this benchmark. Historically, Takeda Pharmaceutical Co's own Dividend Yield % has ranged from 2.71 to 6.17 over the past decade. While the company's 10-year median is 4.39 vs. the industry median of 2.01, Takeda Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.01, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takeda Pharmaceutical Co's current Dividend Yield % of 3.92% is 95.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current Dividend Yield % is 3.92%, which is 11% below median its own 10-year median of 4.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,528.56, compared to a current price of 円5,054.00 — trading 11.6% above its estimated fair value. The current Dividend Yield % is 3.92%, which is 11% below median its 10-year median of 4.39 and 95.5% above the Drug Manufacturers industry median of 2.01. Takeda Pharmaceutical Co's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Dividend Yield % is 3.92% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円5,054.00 is trading 11.6% above its estimated GF Value™ of 円4,528.56.
GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4502:
Dividend Yield %: 3.92% (11% below median its 10-year median of 4.39)
GF Value™: 円4,528.56 vs. price of 円5,054.00 (11.6% above fair value)
Industry Position: 95.5% above the Drug Manufacturers median (#105 of 516)
No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
64GF Score
Get the complete analysis for TSE:4502
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4502 has been successfully added to your 
